Small Molecule Focus
Our entire scientific platform is built around the chemistry and biology of small molecule therapeutics.
From Target to IND.One Partner,One Pipeline.
Integrated non-clinical development for small molecule therapeutics, connecting partners in Europe and North America with China and the Middle East.
Start a ProjectAbout Us
An extension of your R&D team
We connect computational design, synthesis and in vitro and in vivo studies from the start, so risks surface sooner and your budget goes further on the way to IND.
Reliable, Auditable Data
Every dataset is documented and traceable, ready for regulatory review.
Direct Scientific Access
Work directly with senior scientists on timelines that fit the pace of your program.
One Integrated Pipeline
Discovery, preclinical, CMC and regulatory work under one roof, with no hand-offs between vendors.
Our Process
A clear path to the clinic
-
Step 01 Target Validation
Confirm the link between your target and the disease.
-
Step 02 Hit Discovery
Find viable chemical starting points.
-
Step 03 Lead Optimization
Balance potency, selectivity and drug-like properties.
-
Step 04 Preclinical Candidate
Profile PK, efficacy and safety.
-
Step 05 IND Submission
Compile and present the non-clinical package.
Our Services
Integrated capabilities across non‑clinical development
- Target identification and validation
- Assay development and screening
- Hit identification and lead optimization
- Medicinal chemistry and compound synthesis
- In vitro and in vivo pharmacology
- Early efficacy and proof-of-concept studies
From target identification to lead candidate selection.
- In vitro and in vivo ADME, PK/PD and bioanalysis
- Disease models and in vivo efficacy studies
- Dose range-finding and tolerability studies
- GLP and non-GLP toxicology studies
- Safety pharmacology, genotoxicity and carcinogenicity
- Short-term and chronic toxicity assessments
From candidate selection to IND-enabling studies.
- Bioanalytical method development and validation
- Pharmacokinetic and toxicokinetic analysis
- Biomarker development and analysis
- Clinical pathology and laboratory testing
- Histopathology and microscopic evaluations
- Sample management and analytical reporting
Comprehensive analytical support throughout drug development.
- Formulation analytical method development and validation
- Dose formulation concentration and homogeneity testing
- Formulation stability assessments
- Test article handling, storage and distribution
- Sample and reference material management
- Analytical testing and documentation
Analytical, formulation and material management support for preclinical development.
- Regulatory development planning and support
- Nonclinical and clinical regulatory documentation
- Scientific and regulatory medical writing
- Regulatory data review and gap analysis
- IND/CTA preparation and submission support
- Regulatory compliance and quality documentation
Scientific and regulatory documentation support throughout drug development.
- GLP, GCP and GMP compliance support
- Quality assurance audits and inspections
- Study documentation and quality control
- Regulatory inspection readiness
- Vendor and laboratory qualification
- Quality management and risk assessment
Quality oversight and regulatory compliance across research and development.
Expertise
Disease-agnostic platforms, focused experience
Our platforms support any indication, with particular depth in:
- Oncology & Immuno-oncology
- CNS & Neurodegenerative Diseases
- Inflammatory & Autoimmune Disorders
- Metabolic & Cardiovascular Diseases
Contact
Let’s talk about your program
Whether you are validating a target or preparing your final IND package, our team is ready to help.
OfficeFlat 203, Block D, Hoi Lok Court, Cheung Sha Wan, Kowloon, Hong Kong
Thank you!
Your message has been sent. We will get back to you within one business day.